文献速递泌尿男性生殖肿瘤支持与姑息治疗

高ω-3低ω-6饮食联合鱼油用于主动监测前列腺癌男性:CAPFISH-3随机临床试验

High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial.
PubMed 文献 · J Clin Oncol · 2024-12-13

这项II期前瞻性随机试验纳入100例接受主动监测的1或2级组前列腺癌男性,随机分入高ω-3低ω-6饮食联合鱼油胶囊组或对照组,比较基线与1年同部位活检Ki-67指数变化。联合组Ki-67指数从基线1.34%降至1年1.14%,对照组从1.23%升至1.52%,组间变化差异有统计学意义(95%CI 2%至52%,P=0.043);联合组4例因鱼油相关不良事件退出。

要点

  • 联合组Ki-67指数1年时下降约15%,对照组上升约24%,组间变化差异有统计学意义(P=0.043)。
  • 分级组、肿瘤长度、Decipher基因组评分及前列腺特异性抗原两组间无显著差异。
  • 联合组4例因鱼油相关不良事件退出试验。

核心结论

  • 高ω-3低ω-6饮食联合鱼油胶囊1年使Ki-67指数显著降低,该指标为前列腺癌进展、转移和死亡的生物标志物。
  • 这些发现支持未来开展纳入该干预的III期试验。

研究设计与样本

  • II期前瞻性随机试验,纳入100例选择主动监测的1或2级组前列腺癌男性,随机分入饮食联合鱼油胶囊组或对照组。
  • 基线与1年时获取同部位前列腺活检,主要终点为两组间基线至1年同部位活检Ki-67指数变化。

主要发现

  • 联合组Ki-67指数从基线1.34%降至1年1.14%,下降约15%。
  • 对照组Ki-67指数从基线1.23%升至1年1.52%,上升约24%。
  • 两组间Ki-67指数变化差异有统计学意义(95%CI 2%至52%,P=0.043)。
  • 分级组、肿瘤长度、Decipher基因组评分及前列腺特异性抗原等次要结局两组间无显著差异。
  • 联合组4例因鱼油相关不良事件退出试验。

局限性

  • 联合组4例因鱼油相关不良事件退出试验。
  • 原文结论提出这些发现支持未来开展纳入该干预的III期试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Men on active surveillance (AS) for prostate cancer are extremely interested in dietary changes or supplements to prevent progression of their disease. We sought to determine whether a high omega-3, low omega-6 fatty acid diet with fish oil capsules (D + FO) decreases proliferation (Ki-67) in prostate biopsies in men with prostate cancer on AS over a 1-year time period. METHODS: In this phase II, prospective randomized trial, men (N = 100) with grade group 1 or 2 prostate cancer who elected AS were randomly assigned to the D + FO or a control group. Same-site prostate biopsies were obtained at baseline and 1 year. The primary end point was the change in Ki-67 index from baseline to 1 year from same-site biopsies compared between the groups. RESULTS: The Ki-67 index decreased in the D + FO group by approximately 15% from baseline to 1 year (1.34% at baseline, 1.14% at 1 year) and increased in the control group by approximately 24% from baseline to 1 year (1.23% at baseline, 1.52% at 1 year), resulting in a statistically significant difference in the change of Ki-67 index between the groups (95% CI, 2% to 52%, P = .043). There was no significant difference in the secondary outcomes grade group, tumor length, Decipher genomic score, or prostate-specific antigen between the two groups. Four patients in the D + FO group were withdrawn from the trial because of adverse events related to the FO. CONCLUSION: A high omega-3, low omega-6 diet with FO for 1 year resulted in a significant reduction in Ki-67 index, a biomarker for prostate cancer progression, metastasis, and death. These findings support future phase III trials incorporating this intervention in men on AS.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Aronson WJ, Grogan T, Liang P, et al. High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial. J Clin Oncol. 2024. PMID: 39671538. doi:10.1200/JCO.24.00608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。